Historic Milestone Achieved: USDA Approves First-Ever Import of Live Vaccine into the United States.
Willmar, Minnesota — Vaxxinova US proudly announces a groundbreaking development for animal health and the poultry industry. The United States Department of Agriculture (USDA) has approved importation of a live Avian metapneumovirus vaccine, Vaxxon® SHS, into the U.S. market. This unprecedented approval marks a significant milestone in the fight against Avian metapneumovirus (aMPV). Vaxxon® SHS […]
Read more →
Vaxxinova receives EU marketing approval for Vaxxon® ND Clone.
Nijmegen, NL / Brescia, IT, November 28, 2024 – Today Vaxxinova® is pleased to announce that the European Commission has granted a marketing authorization for the poultry vaccine 𝗩𝗮𝘅𝘅𝗼𝗻® 𝗡𝗗 𝗖𝗹𝗼𝗻𝗲 in the EU. The adoption follows the positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency […]
Read more →
CVMP positive opinion for Vaxxon® ND Clone from Vaxxinova®
Nijmegen, NL / Brescia, IT, October 15 2024 – Today Vaxxinova is pleased to announce that the Committee for Medicinal Products for Veterinary Use (CVMP)has adopted a positive opinion, recommending the approval of Vaxxon ND Clone in the EU. Vaxxon ND Clone is a vaccine for active immunization of chickens (broilers, future layers and breeders) […]
Read more →
Vaxxinova®
Vaxxinova is committed to disease prevention in production animals. We aim to provide a complete set of vaccines and diagnostic services, supported by our global R&D network. Vaxxinova believes in ‘business without borders’ and long term partnerships with veterinarians and animal health professionals. We work together in disease prevention and livestock performance improvement programs. Our technical teams can advise you on our products and services.